NCT03682029: Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
- State
- State not given
- Phase
- No phase
- People
- 109 taking part
- Started
- 21 Nov 2017
- Primary completion
- 27 Sep 2023
- Arms
- Vitamin C
- Results
- None posted
- 21 Nov 2017: Trial started
- 24 Sep 2018: Trial registered